Prostate Cancer - Results from #180

Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial. October 4, 2024

Prevalence and Factors Associated With Prostate Cancer Among Transgender Women. October 4, 2024

Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases. October 4, 2024

Pathological Assessment of Men with Grade Group 2 Prostate Cancer. October 3, 2024

Genomic Landscape in Prostate Cancer in a Latin American Population. October 3, 2024

Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer. October 3, 2024

Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor. October 3, 2024

Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2). October 3, 2024

Clarity’s COBRA Study Selected as a Top-Rated Oral Presentation at Prestigious Industry Annual Meeting October 2, 2024

Testosterone Therapy in Men After Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer. October 2, 2024

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer. October 2, 2024

Dissecting the Significance of Acid Phosphatase 1 Gene Alterations in Prostate Cancer. October 2, 2024

Novel intraprostatic MR-guided implantation of multidrug-eluting microdevice for testing of systemic therapy agents in situ; Proof of concept in intermediate- and high-risk prostate cancer. October 2, 2024

When is prostate cancer really cancer? October 2, 2024

CAncer or Not Cancer: Evaluating and Reconsidering GG1 prostate cancer (CANCER-GG1?) October 1, 2024

Partial prostatectomy for localized prostate cancer. October 1, 2024

Changing times: trends in risk classification, tumor upstaging, and positive surgical margins after radical prostatectomy - results from a contemporary National Cancer Database study. October 1, 2024

Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2). October 1, 2024

The Role of Whole-Gland and Focal Cryotherapy in Recurrent Prostate Cancer. October 1, 2024

Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway. October 1, 2024

Page 10 of 1437